Clinical Trials Browser

Phase 3 × Ganglioneuroblastoma × Nuclear Medicine Department, Hospital × Clear all

NCT06172296 2026-06-03

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

Phase 3 Recruiting

Neuroblastoma, Ganglioneuroblastoma